z-logo
Premium
Intermediate dose cyclophosphamide combined with a growth factor is a safe and effective regimen for mobilisation of peripheral blood progenitor cells
Author(s) -
GOSS G.,
SZER J.,
GRIGG A.
Publication year - 1996
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1996.tb01931.x
Subject(s) - medicine , hematology , regimen , cyclophosphamide , bone marrow , bone marrow transplant , oncology , chemotherapy , bone marrow transplantation

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here